Clarus Ventures
VC
INVESTOR TYPE
Active
STATUS
13
PROFESSIONALS
106
INVESTMENTS
25
PORTFOLIO
53
EXITS
Description
Clarus Ventures is a venture capital investments firm that primarily focuses on life sciences. It prefers to invests in companies operating in the life science, pharma, medical device research, biotechnology and healthcare sectors. The firm was founded in 2005 and is based in Cambridge, Massachusetts.
Website
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
2005
Primary Investor Type
Venture Capital
Primary Office
- 101 Main Street
- Suite 1210
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
Clarus Ventures Investments & Acquisitions (106)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Talaris Therapeutics | 18-Apr-2019 | Later Stage VC | 00000 | Biotechnology | Clinical Trials - Phase 3 | 00000000 000000000 00.0 |
| 000000 00000000000 | 18-Feb-2019 | 00000 00000 | 00000 | Biotechnology | Startup | 00000000 000000000 00.0 |
| 000000 00000000000 | 30-Aug-2018 | 00000 00000 | 00000 | Biotechnology | Clinical Trials - Phase 3 | 000000 0000000000 00.0 |
| 0000000 000000 | 13-Jun-2018 | 00000 00000 | 000.00 | Drug Delivery | Startup | 000000 0000000000 00.0 |
| 0000000 | 02-Feb-2018 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 2 | 00000 0000000 00 |
| 00000 00000 | 17-Oct-2017 | 00000 00000 | 0000 | Biotechnology | Clinical Trials - Phase 1 | 000000 000000 00.0 |
| 000000000 00000000 | 07-Sep-2017 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue/Not Profitable | 00000000 00000 |
| 0000000 0000000000 | 05-Sep-2017 | 00000 00000 | 000.00 | Biotechnology | Generating Revenue/Not Profitable | 00000000 000000000 00.0 |
| Tisbury Pharmaceutical | 07-Jun-2017 | Early Stage VC | 0000 | Pharmaceuticals | Out of Business | 000000 0000000000 00.0 |
| Avrobio | 30-Mar-2017 | Early Stage VC | 0000 | Biotechnology | Clinical Trials - Phase 2 | 00000 0000000 00 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Clarus Ventures’s full profile, request a free trial.
Clarus Ventures Exits (53)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Gritstone Oncology | 28-Sep-2018 | IPO | 00000 | Completed |
|
| 0000000 0000000000 | 26-Sep-2018 | 000 | 0000 | Completed |
|
| 00000 00000 | 28-Jun-2018 | 000 | 00000 | Completed |
|
| 0000000 | 21-Jun-2018 | 000 | 00000 | Completed |
|
| 000000 000000000 | 16-Apr-2018 | 000000000 00000000 | Completed |
|
|
| 00000000000 000000 | 12-Oct-2017 | 000 | 0000 | Completed |
|
| 00000000 | 01-Jun-2017 | 0000000000: 000000 | Completed |
|
|
| 0000000000 0000000 | 24-Apr-2017 | 000000000 00000000 | Completed |
|
|
| Sientra | 31-Mar-2017 | Secondary Transaction - Open Market | Completed |
|
|
| Novan | 21-Sep-2016 | IPO | 000.00 | Completed |
|
Clarus Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore Clarus Ventures‘s full profile, request access.
Request full access to PitchBookClarus Ventures Team (34)
8 Former Team Members
You’re viewing 5 of 34 team members. Get the full list »Clarus Ventures Co-Investors (61)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| New Enterprise Associates | 4 | 0 | |
| Frazier Healthcare Partners | 0 | 0 | |
| Nan Fung Life Sciences | 0 | 0 | |
| Novo Holdings | 0 | 0 | |
| OrbiMed | 0 | 0 |